2025-06-25 00:32:20
Latest Post
Supreme Infrastructure India Ltd receives contract worth Rs. 450 crore
CarTrade Labs to Drive Innovation and Shape the Future of Technology
Solarium Green Energy Ltd receives order worth Rs. 35.32 crore
RITES Ltd receives LoI from Gujarat Urban Development Company Ltd
BLS E-Services subsidiary has signed definitive agreement to acquire CSPs of SBI & HDFC Bank
Stock Report
Neuland Laboratories Ltd Q4 FY2025 consolidated net profit declines to Rs. 27.80 crores
Posted On : 2025-05-15 22:18:21( TIMEZONE : IST )
Neuland Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 335.8243 crores during the period ended March 31, 2025 as compared to Rs. 401.9374 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. 27.8059 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 101.5868 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. 21.67 for the period ended March 31, 2025 as compared to Rs. 79.18 for the period ended December 31, 2024.
| Financials | Q4 FY2025 | Q3 FY2025 | % Change |
| Total Income | ₹ 335.8243 crs | ₹401.9374 crs |  -16.45% |
| Net Profit | ₹27.8059 crs | ₹101.5868 crs | -72.63% |
| EPS | ₹21.67 | ₹79.18 | -72.63% |
Financial Results (Q4 FY2025) - YoY Comparison
The company has reported total income of Rs. 335.8243 crores during the period ended March 31, 2025 as compared to Rs.390.3667 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.27.8059 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.67.5619 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.21.67 for the period ended March 31, 2025 as compared to Rs.52.66 for the period ended March 31, 2024.
| Financials | Q4 FY2025 | Q4 FY2024 | % Change |
| Total Income | ₹ 335.8243 crs | ₹390.3667 crs | -13.97% |
| Net Profit | ₹27.8059 crs | ₹67.5619 crs | -58.84% |
| EPS | ₹21.67 | ₹52.66 | -58.85% |
Financial Results (Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.1497.3466 crores during the Financial Year ended March 31, 2025 as compared to Rs.1571.1248 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.260.1081 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.300.0789 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.202.74 for the Financial Year ended March 31, 2025 as compared to Rs.233.89 for the Financial Year ended March 31, 2024.
| Financials | Year Ended FY2025 | Year Ended FY2024 | % Change |
| Total Income | ₹1497.3466 crs | ₹1571.1248 crs | -4.70% |
| Net Profit | ₹260.1081 crs | ₹300.0789 crs | -13.32% |
| EPS | ₹202.74 | ₹233.89 | -13.32% |
Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 11870.35 as compared to the previous close of Rs. 12472.30. The total number of shares traded during the day was 2908 in over 1126 trades.
The stock hit an intraday high of Rs. 12649.00 and intraday low of 11829.05. The net turnover during the day was Rs. 35066998.00.
